
Level-KSachet
Incepta Pharmaceuticals Ltd.
Sodium Polystyrene Sulfonate is a potassium-binding (cation-exchange) resin used for the treatment of hyperkalemia (elevated blood potassium).
Sodium Polystyrene Sulfonate is a potassium-binding (cation-exchange) resin used for the treatment of hyperkalemia (elevated blood potassium).
It does not treat the underlying cause of hyperkalemia and is not intended for routine long-term use given its gastrointestinal and sodium-load risks.
Dosing of Sodium Polystyrene Sulfonate is individualized based on the degree of hyperkalemia and the patient's response, with frequent monitoring of serum potassium.
| Indication / Population | Route | Typical Dose |
|---|---|---|
| Adult hyperkalemia | Oral | 15 g suspended in water or a compatible vehicle, given 1 to 4 times daily (total range approximately 15–60 g/day), adjusted to potassium response |
| Adult hyperkalemia (when oral not feasible/tolerated) | Rectal (retention enema) | 30–50 g as a warm suspension, retained as long as possible, repeated approximately every 6 hours as needed |
| Pediatric hyperkalemia | Oral (with caution) / Rectal | Lower, weight-based doses calculated on an approximate 1 mEq potassium removed per gram of resin basis; individualized by a physician. Oral use is contraindicated in neonates. |
See Dosage and Administration sections below, and Precautions and Warnings, for important safety limits on duration and monitoring.
The following side effects have been reported with Sodium Polystyrene Sulfonate.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.